Sun Pharma Acquires Organon for $11.75 Billion — India’s Biggest Pharma Bet Goes Global
Sun Pharma has agreed to buy US-based Organon for $11.75 billion in cash, India’s biggest overseas pharma deal in decades and a defining bet on women’s health and biosimilars.
Camron White